Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	220.63M -16.2%
Revenue (ttm)	335.01M -2.3%
Net Income	4.42M -59.0%
EPS	0.05
Shares Out	81.41M
PE Ratio	51.58
Forward PE	13.55
Dividend	0.05 (1.81%)
Ex-Dividend Date	May 21, 2026

Volume	8,415
Open	2.700
Previous Close	2.700
Day's Range	2.680 - 2.710
52-Week Range	2.320 - 3.400
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,400
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.